| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.29 | 9e-19 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.32 | 3e-18 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-17 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-16 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-16 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-16 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-15 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-15 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.26 | 7e-15 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-14 |